Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hydralazine 2mg/5ml oral liquid
0205010J0AABIBI
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 35mg/5ml oral suspension
0205010J0AABSBS
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 3mg/5ml oral liquid
0205010J0AABHBH
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 4mg/5ml oral liquid
0205010J0AABFBF
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 50mg/5ml oral liquid
0205010J0AAA4A4
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 62.5mg/5ml oral liquid
0205010J0AABABA
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 7.5mg/5ml oral liquid
0205010J0AAA7A7
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 75mg/5ml oral liquid
0205010J0AAA6A6
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydrochlorothiazide 12.5mg/5ml oral liquid
0202010L0AAAJAJ
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrochlorothiazide 15mg/5ml oral liquid
0202010L0AAANAN
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrochlorothiazide 20mg/5ml oral liquid
0202010L0AAALAL
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrochlorothiazide 250mg/5ml oral liquid
0202010L0AAAXAX
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrochlorothiazide 25mg/5ml oral liquid
0202010L0AAAMAM
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrochlorothiazide 6.25mg/5ml oral liquid
0202010L0AAAKAK
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrochlorothiazide 60.8mg/5ml oral liquid
0202010L0AAAUAU
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrochlorothiazide 6mg/5ml oral liquid
0202010L0AAAVAV
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrochlorothiazide 7mg/5ml oral liquid
0202010L0AAAQAQ
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrosaluric 25mg tablets
0202010L0BCAAAB
|
Hydrosaluric | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hydrosaluric 50mg tablets
0202010L0BCABAC
|
Hydrosaluric | Hydrochlorothiazide | Cardiovascular System | No data available |
|
Hygroton 50mg tablets
0202010F0BBAAAA
|
Hygroton | Chlortalidone | Cardiovascular System | No data available |
|
Hypolar Retard 10mg tablets
0206020R0BQACAE
|
Hypolar | Nifedipine | Cardiovascular System | No data available |
|
Hypolar Retard 20 tablets
0206020R0BQAAAR
|
Hypolar | Nifedipine | Cardiovascular System | No data available |
|
Hypolar XL 30 tablets
0206020R0BQABAN
|
Hypolar | Nifedipine | Cardiovascular System | No data available |
|
Hypoloc 5mg tablets
0204000ABBCAAAA
|
Hypoloc | Nebivolol | Cardiovascular System | No data available |
|
Hypovase 2mg tablets
0205040S0BBACAD
|
Hypovase | Prazosin hydrochloride | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.